[Federal Register Volume 67, Number 109 (Thursday, June 6, 2002)]
[Notices]
[Pages 38943-38944]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 02-14227]


-----------------------------------------------------------------------

DEPARTMENT OF DEFENSE

Department of the Army


Availability for Non-Exclusive, Exclusive, or Partially Exclusive 
Licensing of U.S. Patent Concerning Site-Directed Mutagenesis of 
Esterases

AGENCY: Department of the Army, DOD.

ACTION: Notice.

-----------------------------------------------------------------------

SUMMARY: In accordance with 37 CFR 404.6 and 404.7, announcement is 
made of the availability for licensing of U.S. Patent No. 6,001,625 
entitled ``Site-Directed Mutagenesis of Esterases,'' issued December 
14, 1999. The United States Government, as represented by the Secretary 
of the Army has rights in this invention.

ADDRESSES: Commander, U.S. Army Medical Research and Materiel Command, 
ATTN: Command Judge Advocate, MCMR-JA, 504 Scott Street, Fort Detrick, 
Frederick, MD 21702-5012.

FOR FURTHER INFORMATION CONTACT: For patent issues, Ms. Elizabeth 
Arwine, Patent Attorney, (301) 619-7808. For licensing issues, Dr. Paul 
Mele, Office of Research & Technology Assessment, (301) 619-6664, both 
at telefax (301) 619-5034.

[[Page 38944]]


SUPPLEMENTARY INFORMATION: A method of modifying esterases by 
substitution with histadine of at least one amino acid within 6 A deg. 
of an active site serine provides esterases useful for detoxifying 
organophasphates.

Luz D. Ortiz,
Army Federal Register Liaison Officer.
[FR Doc. 02-14227 Filed 6-5-02; 8:45 am]
BILLING CODE 3710-08-M